Ignite Creation Date:
2024-05-06 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 2:24 PM
Study NCT ID:
NCT05228158
Status:
RECRUITING
Last Update Posted:
2023-12-18
First Post:
2022-01-27
Brief Title:
A Study of Tazemetostat on Safety in Participants With Relapsed or Refractory Follicular Lymphoma With Enhancer of Zeste Homolog 2 EZH2 Gene Mutation in Japan
Sponsor:
Eisai Co Ltd
Organization:
Eisai Inc